perinatal management of maternal SSRI and SNRI use

perinatal management of maternal SSRI and SNRI use - H28-NHO (Development) -02

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026774

Enrollment

100

Registered

2017-03-31

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: neonates of maternal SSRI, SNRI use in third trimester of pregnancy

Exclusion criteria

Exclusion criteria: no record

Design outcomes

Primary

Measure	Time frame
neonatal withdrawal syndrome score	—

Secondary

Measure	Time frame
Severe poor neonatal adaptation PPHN neonatal oxygen use	—

Countries

Japan

Contacts

Public ContactKAWADA Kou

NHO Kyoto Medical Center Pediatrics

kawada@kms.ac.jp075-641-9161

Outcome results